VBI Vaccines Inc/BC Finite-Lived Intangible Assets, Net
VBI Vaccines Inc/BC had Finite-Lived Intangible Assets, Net of $40.34 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2023-08-14
- 2023-06-30: Finite-Lived Intangible Assets, Net $40.34M.
- 2023-03-31: Finite-Lived Intangible Assets, Net $58.50M.
- 2022-12-31: Finite-Lived Intangible Assets, Net $58.34M.
- 2022-09-30: Finite-Lived Intangible Assets, Net $57.73M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2023-06-30 | $40.34M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $58.50M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $58.34M 10-Q · filed 2023-08-14 |
| 2022-09-30 | $57.73M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $61.38M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $63.22M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $62.09M 10-K · filed 2023-03-13 |
| 2021-09-30 | $62.15M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $63.87M 10-Q · filed 2021-08-02 |
| 2021-03-31 | $62.74M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $62.16M 10-K · filed 2022-03-07 |
| 2017-09-30 | $63.67M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $61.53M 10-Q · filed 2017-07-31 |
| 2017-03-31 | $59.98M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $59.51M 10-Q · filed 2017-11-13 |
| 2015-12-31 | $12.80M 10-K · filed 2017-03-20 |